FindTrial
Sign In

Study on the Effect and Mechanism of Th17 Cells and Treg cells on the Progression of interstitial pneumonia with autoimmune features

Study on the Effect and Mechanism of Th17 Cells and Treg cells on the Progression of interstitial pneumonia with autoimmune features

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-17014014
Enrollment
Unknown
Registered
2017-12-18
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial pneumonia with autoimmune features

Interventions

Case series:Nil

Sponsors

Tianjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: The European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung Disease offers classification criteria organised around the presence of a combination of features from three domains: a clinical domain consisting of specific extra-thoracic features, a serologic domain consisting of specific autoantibodies, and a morphologic domain consisting of specific chest imaging, histopathologic or pulmonary physiologic features.

Exclusion criteria

Exclusion criteria: 1. UIP; 2. CTD; 3. associated with asthma; 4. associated with COPD; 5. associated with lung tuberculosis; 6. associated with bronchiectasis; 7. associated with other respiratory diseases; 8. associated with tumor.

Design outcomes

Primary

MeasureTime frame
Th17 cell;Treg cell;IL-17;IL-10;—

Countries

China

Contacts

Public ContactZhao Lihong

Tianjin First Center Hospital

zhaolihong4605@163.com+86 13752145615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026